Femme et Homme
- | Pays :
- Russian Federation
- Lebanon
- Ukraine
- | Organes : -
- | Spécialités : -
Extrait
Primary Objective: -To demonstrate the efficacy of a fixed combination of glimepiride + metformin in terms of HbA1c reduction, during 24-week treatment period in patients with inadequately controlled type 2 diabetes mellitus. Secondary Objective: To assess the effects of the fixed combination of glimepiride and metformin at week 24 on: - Percentage of patients reaching HbA1c <7% - Percentage of patients reaching HbA1c <6.5%. - Fasting Plasma Glucose (FPG) - Safety and tolerability
Critère d'inclusion
- Type 2 diabetes mellitus